ANDEXANET ALFA ANDEXXA ANTICOAGULATION REVERSAL DIRECT ORAL ANTICOAGULANT REVERSAL DOAC REVERSAL FOUR-FACTOR PCC PCC UNCATEGORIZED
Andexxa Vs 4F-PCC in ICH: An Ongoing Debate

Read more

ANDEXANET ALFA ANTICOAGULATION REVERSAL DIRECT ORAL ANTICOAGULANT REVERSAL DIRECT ORAL ANTICOAGULANTS DOAC DOAC REVERSAL DOACS FOUR-FACTOR PCC ICH INTRACRANIAL HEMORRHAGE UNCATEGORIZED
Andexanet Alfa Vs. Four-Factor PCC: Is Andexanet Alfa Worth The Hype?

Read more

ANDEXANET ALFA ANNEXA-4 HEMATOLOGY UNCATEGORIZED
ANNEXA-4: Andexanet Alfa and Factor Xa Inhibitors

Read more

ABIXIBAN ANDEXANET ALFA DABIGITRAN EM CASES EMERGENCY MEDICINE EPISODES EPISTAXIS GASTROENTEROLOGY GI BLEED HEMATOLOGY ICH IDARUCIZUMAB JIM DOUKETIS MEDICAL SPECIALTY NEUROLOGY PCCS RIVAROXIBAN WALTER HIMMEL
Episode 89 – DOACs Part 2: Bleeding and Reversal Agents

In this Part 2, DOACs Bleeding and Reversal we discuss the management of bleeding in patients taking DOACs with minor risk bleeds, like epistaxis where local control is easy to access, moderate risk bleeds, like stable GI bleeds and high risk bleeds, like intracranial hemor...

Read more
ABIXIBAN ANDEXANET ALFA DABIGITRAN EM CASES EMERGENCY MEDICINE EPISODES EPISTAXIS GASTROENTEROLOGY GI BLEED HEMATOLOGY ICH IDARUCIZUMAB JIM DOUKETIS MEDICAL SPECIALTY NEUROLOGY PCCS RIVAROXIBAN WALTER HIMMEL
Episode 89 – DOACs Part 2: Bleeding and Reversal Agents

In this Part 2, DOACs Bleeding and Reversal we discuss the management of bleeding in patients taking DOACs with minor risk bleeds, like epistaxis where local control is easy to access, moderate risk bleeds, like stable GI bleeds and high risk bleeds, like intracranial hemor...

Read more

Designed and developed by MED-TAC International Corp.